{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:22:51Z","timestamp":1740144171529,"version":"3.37.3"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T00:00:00Z","timestamp":1722556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T00:00:00Z","timestamp":1722556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["PharmacoEconomics"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s40273-024-01422-7","type":"journal-article","created":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T13:40:09Z","timestamp":1722606009000},"page":"1237-1239","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Delaying Oral Anticoagulants: A False Economy?"],"prefix":"10.1007","volume":"42","author":[{"given":"Brendan","family":"Collins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7566-1626","authenticated-orcid":false,"given":"Gregory Y. H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,2]]},"reference":[{"key":"1422_CR1","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/ehjqcco\/qcaa093","volume":"8","author":"P Burdett","year":"2022","unstructured":"Burdett P, Lip GYH. Atrial fibrillation in the UK: predicting costs of an emerging epidemic recognizing and forecasting the cost drivers of atrial fibrillation-related costs. Eur Heart J Qual Care Clin Outcomes. 2022;8:187\u201394.","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"1422_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-024-01419-2","author":"R Mulholland","year":"2024","unstructured":"Mulholland R, Ciminata G, Quinn T, Geue C. Delay and pay? Healthcare costs associated with late oral anti-coagulant prescribing in people with atrial fibrillation. Pharmacoeconomics. 2024. https:\/\/doi.org\/10.1007\/s40273-024-01419-2.","journal-title":"Pharmacoeconomics"},{"key":"1422_CR3","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1093\/ehjqcco\/qcac005","volume":"8","author":"P Burdett","year":"2022","unstructured":"Burdett P, Lip GYH. Targeted vs. full population screening costs for incident atrial fibrillation and AF-related stroke for a healthy population aged 65 years in the United Kingdom. Eur Heart J Qual Care Clin Outcomes. 2022;8:892\u20138.","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"1422_CR4","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.jval.2023.12.015","volume":"27","author":"A Buja","year":"2024","unstructured":"Buja A, Rebba V, Montecchio L, Renzo G, Baldo V, Cocchio S, Ferri N, Migliore F, Zorzi A, Collins B, Amrouch C, De Smedt D, Kypridemos C, Petrovic M, O\u2019Flaherty M, Lip GYH. The cost of atrial fibrillation: a systematic review. Value Health. 2024;27:527\u201341.","journal-title":"Value Health"},{"key":"1422_CR5","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jval.2020.10.001","volume":"24","author":"R Cookson","year":"2021","unstructured":"Cookson R, Griffin S, Norheim OF, Culyer AJ, Chalkidou K. Distributional cost-effectiveness analysis comes of age. Value Health. 2021;24:118\u201320.","journal-title":"Value Health"},{"key":"1422_CR6","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euad226","author":"GYH Lip","year":"2023","unstructured":"Lip GYH, Proietti M, Potpara T, Mansour M, Savelieva I, Tse HF, Goette A, Camm AJ, Blomstrom-Lundqvist C, Gupta D, Boriani G. Atrial fibrillation and stroke prevention: 25 years of research at EP Europace journal. Europace. 2023. https:\/\/doi.org\/10.1093\/europace\/euad226.","journal-title":"Europace"},{"key":"1422_CR7","doi-asserted-by":"publisher","unstructured":"Teppo K, Lip GYH, Airaksinen KEJ, Halminen O, Haukka J, Putaala J, Mustonen P, Linna M, Hartikainen J, Lehto M. Comparing CHA2DS2-VA and CHA2DS2-VASc scores for stroke risk stratification in patients with atrial fibrillation: a temporal trends analysis from the retrospective Finnish AntiCoagulation in Atrial Fibrillation (FinACAF) cohort. Lancet Reg Health Eur. 2024. https:\/\/doi.org\/10.1016\/j.lanepe.2024.100967.","DOI":"10.1016\/j.lanepe.2024.100967"},{"key":"1422_CR8","doi-asserted-by":"publisher","DOI":"10.1055\/a-2278-8769","author":"DS Kang","year":"2024","unstructured":"Kang DS, Yang PS, Kim D, Jang E, Yu HT, Kim TH, Sung JH, Pak HN, Lee MH, Lip GYH, Joung B. Racial differences in ischemic and hemorrhagic stroke: an ecological epidemiological study. Thromb Haemost. 2024. https:\/\/doi.org\/10.1055\/a-2278-8769.","journal-title":"Thromb Haemost"},{"key":"1422_CR9","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.mayocp.2023.07.013","volume":"99","author":"B Corica","year":"2024","unstructured":"Corica B, Romiti GF, Proietti M, Mei DA, Boriani G, Chao TF, Olshansky B, Huisman MV, Lip GYH, Investigators G-A. Clinical outcomes in metabolically healthy and unhealthy obese and overweight patients with atrial fibrillation: findings from the GLORIA-AF Registry. Mayo Clinic Proc. 2024;99:927\u201339.","journal-title":"Mayo Clinic Proc"},{"key":"1422_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.885016","volume":"9","author":"SR Lee","year":"2022","unstructured":"Lee SR, Choi EK, Park SH, Lee SW, Han KD, Oh S, Lip GYH. Clustering of unhealthy lifestyle and the risk of adverse events in patients with atrial fibrillation. Front Cardiovasc Med. 2022;9: 885016.","journal-title":"Front Cardiovasc Med"},{"key":"1422_CR11","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1161\/STROKEAHA.123.043812","volume":"55","author":"K Huang","year":"2024","unstructured":"Huang K, Jia J, Liang F, Li J, Niu X, Yang X, Chen S, Cao J, Shen C, Liu X, Yu L, Lu F, Wu X, Zhao L, Li Y, Hu D, Huang J, Liu Y, Gu D, Liu F, Lu X. Fine particulate matter exposure, genetic susceptibility, and the risk of incident stroke: a prospective cohort study. Stroke. 2024;55:92\u2013100.","journal-title":"Stroke"},{"key":"1422_CR12","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1055\/s-0042-1756355","volume":"122","author":"GF Romiti","year":"2022","unstructured":"Romiti GF, Proietti M, Bonini N, Ding WY, Boriani G, Huisman MV, Lip GYH, Investigators G-A. Clinical complexity domains, anticoagulation, and outcomes in patients with atrial fibrillation: a report from the GLORIA-AF Registry Phase II and III. Thromb Haemost. 2022;122:2030\u201341.","journal-title":"Thromb Haemost"},{"key":"1422_CR13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/qjmed\/hcad219","volume":"117","author":"R Krittayaphong","year":"2024","unstructured":"Krittayaphong R, Treewaree S, Wongtheptien W, Kaewkumdee P, Lip GYH. Clinical phenotype classification to predict risk and optimize the management of patients with atrial fibrillation using the Atrial Fibrillation Better Care (ABC) pathway: a report from the COOL-AF registry. QJM. 2024;117:16\u201323.","journal-title":"QJM"},{"key":"1422_CR14","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002197","volume":"5","author":"SD Pokorney","year":"2016","unstructured":"Pokorney SD, Piccini JP, Stevens SR, Patel MR, Pieper KS, Halperin JL, Breithardt G, Singer DE, Hankey GJ, Hacke W, Becker RC, Berkowitz SD, Nessel CC, Mahaffey KW, Fox KA, Califf RM, Committee RAS, Investigators, Investigators RASC. Cause of death and predictors of all-cause mortality in anticoagulated patients with nonvalvular atrial fibrillation: data From ROCKET AF. J Am Heart Assoc. 2016;5: e002197.","journal-title":"J Am Heart Assoc"},{"key":"1422_CR15","doi-asserted-by":"publisher","first-page":"020","DOI":"10.1055\/s-0041-1739411","volume":"122","author":"T-F Chao","year":"2022","unstructured":"Chao T-F, Joung B, Takahashi Y, Lim TW, Choi E-K, Chan Y-H, Guo Y, Sriratanasathavorn C, Oh S, Okumura K. 2021 focused update consensus guidelines of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation: executive summary. Thromb Haemost. 2022;122:020\u201347.","journal-title":"Thromb Haemost"},{"key":"1422_CR16","doi-asserted-by":"publisher","unstructured":"Wang Y, Guo Y, Qin M, Fan J, Tang M, Zhang X, Wang H, Li X, Lip GYH, Expert Reviewers. 2024 Chinese Expert consensus guidelines on the diagnosis and treatment of atrial fibrillation in the elderly, endorsed by Geriatric Society of Chinese Medical Association (Cardiovascular Group) and Chinese Society of Geriatric Health Medicine (Cardiovascular branch): Executive Summary. Thromb Haemost. 2024. https:\/\/doi.org\/10.1055\/a-2325-5923. Epub ahead of print. PMID: 38744425.","DOI":"10.1055\/a-2325-5923"},{"key":"1422_CR17","first-page":"326","volume":"10","author":"EM Camacho","year":"2024","unstructured":"Camacho EM, Lip GY. Estimating the impact of implementing an integrated care management approach with Atrial fibrillation Better Care (ABC) pathway for patients with atrial fibrillation in England from 2020 to 2040. Eur Heart J. 2024;10:326\u201333.","journal-title":"Eur Heart J"},{"key":"1422_CR18","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1055\/s-0043-1772773","volume":"124","author":"S Treewaree","year":"2024","unstructured":"Treewaree S, Lip GYH, Krittayaphong R. Non-vitamin K antagonist oral anticoagulant, warfarin, and ABC pathway adherence on hierarchical outcomes: win ratio analysis of the COOL-AF Registry. Thromb Haemost. 2024;124:69\u201379.","journal-title":"Thromb Haemost"},{"key":"1422_CR19","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.1093\/eurheartj\/ehac265","volume":"43","author":"SP Johnsen","year":"2022","unstructured":"Johnsen SP, Proietti M, Maggioni AP, Lip GYH. A multinational European network to implement integrated care in elderly multimorbid atrial fibrillation patients: the AFFIRMO Consortium. Eur Heart J. 2022;43:2916\u20138.","journal-title":"Eur Heart J"}],"container-title":["PharmacoEconomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40273-024-01422-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40273-024-01422-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40273-024-01422-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T16:18:40Z","timestamp":1729700320000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40273-024-01422-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,2]]},"references-count":19,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["1422"],"URL":"https:\/\/doi.org\/10.1007\/s40273-024-01422-7","relation":{},"ISSN":["1170-7690","1179-2027"],"issn-type":[{"type":"print","value":"1170-7690"},{"type":"electronic","value":"1179-2027"}],"subject":[],"published":{"date-parts":[[2024,8,2]]},"assertion":[{"value":"22 July 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"G.Y.H.L. is a National Institute for Health and Care Research (NIHR) Senior Investigator and co-PI of the AFFIRMO project on multimorbidity in AF (Grant Agreement No. 899871), TARGET project on digital twins for personalised management of atrial fibrillation and stroke (Grant Agreement No. 101136244) and ARISTOTELES project on artificial intelligence for management of chronic long-term conditions (Grant Agreement no. 101080189), which are all funded by the EU\u2019s Horizon Europe Research & Innovation programme.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests and Funding"}}]}}